glp-1 for type 1 diabetes Weight-Loss Drug Use Has Risen Sharply Among Children and Adults With | Johns Hopkins Could GLP-1 Receptor Agonists Help

Zepbound showed superior weight loss over Wegovy in complete SURMOUNT-5 results

As this evidence becomes more robust, more insurance plans will likely expand coverage for GLP-1 drugs in the near future

Market expansion is being driven by the increasing prevalence of obesity, diabetes, and other metabolic disorders, growing health awareness, improving healthcare infrastructure, and greater availability of advanced treatment options

Both semaglutide and tirzepatide have been on the shortage list at various points, which has allowed compounding pharmacies to produce these medications legally

Cardiac Electrophysiology In a randomized, placebo-controlled crossover study, 79 healthy subjects were administered a single oral dose of sitagliptin 100 mg, sitagliptin 800 mg (8 times the recommended dose), and placebo

Handler went to lunch with a girlfriend who said she was nauseous due to being on Ozempic and the comedian said she felt queasy too but chalked it up to being jet-lagged after returning from a trip to Spain